,i #aagth ,,congress #ast ,session ,h4 ,r4 #eggb ,,in ,,the ,,house ,,of ,,representatives ,october #bh1 #bjba,mr4 ,gonzalez of ,ohio 7for himself1 ,mr4 ,kinzinger1 ,ms4 ,wild1 ,mr4 ,crdenas1 ,mr4 ,meijer1 ,mr4 ,peters1 and ,mr4 ,joyce of ,ohio7 introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce1 and in addition to the ,committee on ,science1 ,space1 and ,technology1 for a period to be subsequently determined by the ,speaker1 in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned ,a ,,bill ,to authorize the ,director of the ,national ,science ,foundation to award grants to support research on neurological and psychiatric illnesses associated with ,,covid-#ai infection1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,brycen ,gray and ,ben ,price ,,covid-#ai ,neurological ,impact ,act4 #b4 ,findings ,congress makes the following findings3 7#a7 ,historical epidemiological perspectives suggest an association between exposure to general respiratory viruses and subsequent neurological and psychiatric illnesses4 7#b7 ,early research suggests that one in three patients diagnosed with a ,,covid-#ai infection experiences a neurological or psychiatric illness within six months of such diagnosis4 7#c7 ,research is urgently needed to better understand why neurological and psychiatric illnesses occur in patients following a ,,covid-#ai infection1 so that treatments and therapeutic strategies can be developed4 7#d7 ,the ,national ,science ,foundation and the ,national ,institutes of ,health have a deep history of supporting collaborative research that spans the biological sciences and paves the way for health-related advancements4 #c4 ,national ,science ,foundation research ,the ,director of the ,national ,science ,foundation1 in consultation with the ,director of the ,national ,institutes of ,health and the ,director of the ,national ,institute of ,mental ,health1 is authorized to award grants on a competitive basis to support multidisciplinary research on neurological and psychiatric illnesses associated with ,,covid-#ai infection1 including with respect to children and adolescents4 ,such research may include research into any of the following3 7#a7 ,the incidence of neurological and psychiatric illness associated with ,,covid-#ai infection4 7#b7 ,brain function following a ,,covid-#ai infection and the potential relevance of such infection to neurological and psychiatric illnesses4 7#c7 ,the relevance of psychological and psychosocial factors associated with the ,,covid-#ai pandemic to neurological and psychiatric illnesses1 including an identification and evaluation of such factors4 7#d7 ,other science with potential relevance to the causes1 diagnosis1 prognosis1 and treatment of neurological and psychiatric illnesses associated with ,,covid-#ai infection4 #d4 ,,covid-#ai mental health interagency working group 7a7 ,establishment ,the ,director of the ,office of ,science and ,technology ,policy1 in consultation with the ,national ,science and ,technology ,council1 shall establish an interagency working group-- 7#a7 to coordinate ,federal programs and activities with roles in addressing-- 7,a7 neurological and psychiatric illnesses associated with ,,covid-#ai infection2 and 7,b7 psychological and psychosocial factors associated with the ,,covid-#ai pandemic that may be relevant to such illnesses2 7#b7 to coordinate ,federal research and data collection1 including with respect to children and adolescents-- 7,a7 to identify neurological and psychiatric illnesses associated with ,,covid-#ai infection2 and 7,b7 to improve understanding of psychological and psychosocial factors associated with the ,,covid-#ai pandemic that may be relevant to such illnesses2 and 7#c7 to coordinate engagement with researchers and stakeholders from universities1 industry1 public health organizations1 health care providers1 ,state and local governments1 elementary and secondary educational organizations1 and non-profit organizations to ensure that research1 information1 and best practices relating to neurological and psychiatric illnesses associated with ,,covid-#ai infection are shared among such entities4 7b7 ,co-,chairs ,the interagency working group shall be co-chaired by-- 7#a7 the ,director of the ,office of ,science and ,technology ,policy2 and 7#b7 a member of the interagency working group selected by the ,director of the ,office of ,science and ,technology ,policy4 7c7 ,termination ,the interagency working group shall terminate on the date that is #e years after the date of the enactment of this ,act4